Aclaris Therapeutics Income Statement (2017-2025) | ACRS

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.68M1.00M1.12M3.68M1.12M3.67M1.26M0.89M0.98M1.09M1.41M2.05M1.45M1.58M1.78M1.82M1.66M1.50M1.45M1.53M19.02M7.75M2.53M1.87M9.28M17.57M2.40M2.77M4.35M9.21M1.46M1.78M3.30M
Gross Profit 0.23M0.24M0.15M2.50M0.43M0.16M0.06M-0.11M0.16M0.07M0.14M0.66M0.26M0.29M0.57M0.56M0.56M0.35M0.30M0.46M18.09M6.88M1.72M0.83M8.43M16.84M1.59M2.14M3.69M8.51M0.95M1.26M2.76M
Operating items
Amortization - Intangibles 1.66M1.66M
Research & Development 7.77M7.96M10.86M9.20M13.61M13.98M15.19M19.36M19.64M17.52M16.18M10.83M7.68M6.47M6.24M8.96M7.84M7.90M13.98M14.10M14.31M18.78M23.66M21.07M22.59M25.27M23.88M26.65M9.85M8.76M5.96M9.03M11.58M11.45M13.03M
Selling, General & Administrative 3.72M5.14M4.57M5.52M6.26M8.12M6.14M5.28M7.46M7.47M6.84M6.06M6.20M5.57M3.86M4.90M4.83M5.87M5.98M6.94M6.10M6.08M5.81M7.15M8.79M8.32M7.09M8.21M6.84M4.75M5.65M4.95M6.14M5.39M4.87M
Other Operating Expenses -12.67M-15.43M-17.88M-24.76M-30.23M-31.22M-32.74M-38.55M1.21M19.50M0.83M1.76M3.04M1.39M1.81M1.29M17.64M6.06M2.00M3.35M-0.04M-2.33M10.42M8.61M1.07M0.09M9.89M-13.24M4.64M2.11M3.21M94.91M1.82M3.35M2.55M
Operating Expenses 12.93M15.29M18.99M25.69M32.07M35.65M22.46M39.20M28.31M44.49M23.85M18.65M16.91M13.43M11.91M15.14M30.31M19.83M21.95M24.39M20.36M22.52M39.89M36.83M32.45M33.68M40.86M21.62M21.33M15.62M14.82M108.89M19.54M20.18M20.45M
Operating Income -12.93M-15.29M-18.76M-7.38M-30.95M-31.98M-21.34M-24.04M-27.05M-43.60M-22.86M-17.55M-15.51M-11.38M-10.46M-13.56M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-31.58M-4.05M-18.93M-12.85M-10.47M-99.67M-18.08M-18.41M-17.15M
EBIT -12.93M-15.29M-18.76M-7.38M-30.95M-31.98M-21.34M-24.04M-27.05M-43.60M-22.86M-17.55M-15.51M-11.38M-10.46M-13.56M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-31.58M-4.05M-18.93M-12.85M-10.47M-99.67M-18.08M-18.41M-17.15M
Non-operating items
Interest & Investment Income 2.32M2.19M1.99M1.87M1.99M2.10M2.17M2.02M1.82M
Other Non Operating Income 0.37M0.46M0.56M0.68M0.72M0.76M0.71M0.49M-0.23M-0.09M-0.27M-1.90M0.18M-0.19M-0.19M-0.22M-0.23M-0.15M-0.85M0.09M0.12M0.46M0.92M1.44M1.76M2.25M2.32M2.19M1.99M1.87M
Non Operating Income 0.37M0.46M0.56M0.68M0.72M0.76M0.71M0.49M-0.23M-0.09M-0.27M-1.90M0.18M-0.19M-0.19M-0.22M-0.23M-0.15M-0.85M0.09M0.12M0.46M0.92M1.44M1.76M2.25M2.32M2.19M1.99M1.87M2.88M3.12M3.00M2.98M2.54M
Net income details
EBT -12.93M-15.29M-18.76M-7.38M-30.95M-31.98M-21.34M-24.04M-27.05M-43.60M-22.86M-17.55M-15.51M-11.38M-10.46M-13.56M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-29.26M-1.86M-16.94M-10.99M-8.48M-97.57M-15.92M-16.39M-15.33M
Profit After Tax -12.56M-14.84M-18.19M-22.93M-30.23M-31.22M-32.74M-38.55M-37.56M-49.88M-55.32M-18.59M-15.59M-11.60M-10.66M-13.31M-28.75M-18.16M-21.15M-22.80M-18.79M-20.53M-19.95M-27.64M-28.16M-29.57M-29.26M-1.49M-16.94M-10.99M-7.59M-96.55M-15.09M-15.43M-14.61M
Income from Continuing Operations -12.93M-15.29M-18.76M-7.38M-30.95M-31.98M-21.34M-24.04M-27.05M-43.60M-22.86M-17.55M-15.51M-11.38M-10.46M-13.56M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-29.26M-1.86M-16.94M-10.99M-8.48M-97.57M-15.92M-16.39M-15.33M
Consolidated Net Income -12.93M-15.29M-18.76M-7.38M-30.95M-31.98M-12.11M-14.99M-10.28M-6.19M-32.18M0.85M-0.26M-0.03M-10.46M0.42M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-29.26M-1.86M-16.94M-10.99M-8.48M-97.57M-15.92M-16.39M-15.33M
Income towards Parent Company -12.93M-15.29M-18.76M-7.38M-30.95M-31.98M-12.11M-14.99M-10.28M-6.19M-32.18M0.85M-0.26M-0.03M-10.46M0.42M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-29.26M-1.86M-16.94M-10.99M-8.48M-97.57M-15.92M-16.39M-15.33M
Net Income towards Common Stockholders -12.56M-14.84M-18.19M-22.93M-30.23M-31.22M-32.74M-14.99M-10.28M-6.19M-32.18M0.85M-0.26M-0.03M-10.46M0.42M-28.53M-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-29.26M-1.86M-16.94M-10.99M-8.48M-97.57M-15.92M-16.39M-15.33M
Additional items
EPS (Basic) -0.48-0.56-0.63-0.74-0.98-1.01-1.06-0.99-0.91-1.21-1.34-0.44-0.37-0.28-0.25-0.30-0.57-0.34-0.35-0.37-0.31-0.31-0.30-0.41-0.42-0.42-0.41-0.02-0.24-0.15-0.11-1.21-0.12-0.13-0.12
EPS (Weighted Average and Diluted) 0.020.01-0.57-0.34-0.35-0.37-0.31-0.31-0.30-0.41-0.42-0.42-0.41-0.02-0.24-0.15-0.11-1.21-0.12-0.13-0.12
Shares Outstanding (Weighted Average) 26.09M26.73M26.74M30.83M30.90M30.91M30.98M40.94M41.27M41.27M41.37M41.39M41.53M41.87M42.72M42.92M51.80M52.11M61.22M61.23M61.28M66.58M66.67M66.68M66.69M70.68M70.79M70.84M70.93M71.26M71.34M71.43M107.92M108.28M108.33M
Shares Outstanding (Diluted Average) 41.32M42.54M50.34M53.97M61.22M56.73M61.43M65.99M66.68M65.21M66.87M70.63M70.81M69.81M71.07M71.29M71.38M77.30M122.39M122.58M122.62M
EBITDA -12.54M-14.76M-18.14M-23.07M-30.31M-31.08M-32.67M-38.50M-37.55M-49.82M-55.33M-18.66M-15.47M-11.63M-10.72M-13.22M-28.80M-18.20M-20.96M-23.02M-19.54M-20.89M-20.09M-27.07M-27.62M-30.33M-29.28M-0.47M-17.20M-11.09M-6.70M-96.88M-14.75M-15.38M-14.50M
Shares Outstanding 8.10M